Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H2 | P55055 | 1/20 | 0.47 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.47 |
| ▸ | PPARA | Q07869 | 3/20 | 0.38 |
| ▸ | ANPEP | P15144 | 1/20 | 0.37 |
| ▸ | DPP4 | P27487 | 1/20 | 0.37 |
| ▸ | PPARG | P37231 | 2/20 | 0.37 |
| ▸ | BCL2L2 | Q92843 | 1/20 | 0.36 |
| ▸ | BID | P55957 | 3/20 | 0.35 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.35 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.35 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.35 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.35 |
| ▸ | EP300 | Q09472 | 1/20 | 0.35 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.35 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.35 |
| ▸ | KAT5 | Q92993 | 1/20 | 0.35 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23772449 | 0.89 | NR1H2 (0.39) | NR1H2NR1H3PPARAANPEPDPP4 | |
| SCHEMBL24011915 | 0.87 | NR1H2 (0.39) | NR1H2NR1H3PPARAANPEPDPP4 | |
| SCHEMBL24011808 | 0.83 | RIPK1 (0.39) | NR1H2NR1H3ANPEPDPP4 | |
| SCHEMBL24011932 | 0.82 | PTGS2 (0.41) | — | |
| SCHEMBL24012160 | 0.81 | ANPEP (0.38) | PPARAANPEPDPP4PPARG | |
| SCHEMBL24012195 | 0.81 | ANPEP (0.36) | PPARAANPEPDPP4PPARG | |
| SCHEMBL24012146 | 0.81 | NR1H2 (0.43) | NR1H2NR1H3PPARAANPEPDPP4 | |
| SCHEMBL24012158 | 0.79 | HCRTR1 (0.36) | ANPEPDPP4 | |
| SCHEMBL23772269 | 0.78 | HCRTR1 (0.36) | — | |
| SCHEMBL13498707 | 0.78 | DPP4 (0.46) | ANPEPDPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220003641-A1 | LIGHT-EMITTING COLORANT-CONTAINING PARTICLE, AND LABELING AGENT FOR PATHOLOGICAL DIAGNOSIS | Konica Minolta, Inc. (JP) | 2022-01-06 | — | — | US | disclosed |
| US-20210351356-A1 | IMIDE DERIVATIVE, LUMINESCENT COMPOSITION CONTAINING SAME, LUMINOUS THIN FILM, AND LUMINOUS PARTICLES | Konica Minolta, Inc. (JP) | 2021-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210351356-A1 | IMIDE DERIVATIVE, LUMINESCENT COMPOSITION CONTAINING SAME, LUMINOUS THIN FILM, AND LUMINOUS PARTICLES | IGF1R, IK, BMI1 | NR1H2 1914/4885NR1H3 2587/4885PPARA 3947/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.